Global Pentavalent Vaccine Supply, Demand and Key Producers, 2023-2029
The global Pentavalent Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
A pentavalent vaccine is a five-in-one vaccine that protects against diphtheria, tetanus, and whooping cough, hepatitis B, and Haemophilus influenza type b with just one dosage. One of the most well-known and successful techniques of preventing paediatric diseases is vaccination. The Government of India has achieved tremendous progress in preventing and controlling vaccine-preventable diseases since implementing the Universal Immunization Programme (UIP) (VPDs). The introduction of a pentavalent vaccination will help to minimise the number of cases of pneumonia and meningitis caused by the germs Haemophilus influenzae type b (Hib).
This report studies the global Pentavalent Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pentavalent Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pentavalent Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pentavalent Vaccine total production and demand, 2018-2029, (K Units)
Global Pentavalent Vaccine total production value, 2018-2029, (USD Million)
Global Pentavalent Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Pentavalent Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Pentavalent Vaccine domestic production, consumption, key domestic manufacturers and share
Global Pentavalent Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Pentavalent Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Pentavalent Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Pentavalent Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Serum Institute of India, Panacea Drugs Pvt. Ltd, Shantha Biotechnics, Biological E. Ltd., Novartis AG, Crucell and Bio Farma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pentavalent Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Pentavalent Vaccine Market, By Region:
1. How big is the global Pentavalent Vaccine market?
2. What is the demand of the global Pentavalent Vaccine market?
3. What is the year over year growth of the global Pentavalent Vaccine market?
4. What is the production and production value of the global Pentavalent Vaccine market?
5. Who are the key producers in the global Pentavalent Vaccine market?
6. What are the growth factors driving the market demand?
A pentavalent vaccine is a five-in-one vaccine that protects against diphtheria, tetanus, and whooping cough, hepatitis B, and Haemophilus influenza type b with just one dosage. One of the most well-known and successful techniques of preventing paediatric diseases is vaccination. The Government of India has achieved tremendous progress in preventing and controlling vaccine-preventable diseases since implementing the Universal Immunization Programme (UIP) (VPDs). The introduction of a pentavalent vaccination will help to minimise the number of cases of pneumonia and meningitis caused by the germs Haemophilus influenzae type b (Hib).
This report studies the global Pentavalent Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pentavalent Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pentavalent Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pentavalent Vaccine total production and demand, 2018-2029, (K Units)
Global Pentavalent Vaccine total production value, 2018-2029, (USD Million)
Global Pentavalent Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Pentavalent Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Pentavalent Vaccine domestic production, consumption, key domestic manufacturers and share
Global Pentavalent Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Pentavalent Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Pentavalent Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Pentavalent Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Serum Institute of India, Panacea Drugs Pvt. Ltd, Shantha Biotechnics, Biological E. Ltd., Novartis AG, Crucell and Bio Farma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pentavalent Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Pentavalent Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Lyophilized
- Liquid
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- Serum Institute of India
- Panacea Drugs Pvt. Ltd
- Shantha Biotechnics
- Biological E. Ltd.
- Novartis AG
- Crucell
- Bio Farma
1. How big is the global Pentavalent Vaccine market?
2. What is the demand of the global Pentavalent Vaccine market?
3. What is the year over year growth of the global Pentavalent Vaccine market?
4. What is the production and production value of the global Pentavalent Vaccine market?
5. Who are the key producers in the global Pentavalent Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Pentavalent Vaccine Introduction
1.2 World Pentavalent Vaccine Supply & Forecast
1.2.1 World Pentavalent Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Pentavalent Vaccine Production (2018-2029)
1.2.3 World Pentavalent Vaccine Pricing Trends (2018-2029)
1.3 World Pentavalent Vaccine Production by Region (Based on Production Site)
1.3.1 World Pentavalent Vaccine Production Value by Region (2018-2029)
1.3.2 World Pentavalent Vaccine Production by Region (2018-2029)
1.3.3 World Pentavalent Vaccine Average Price by Region (2018-2029)
1.3.4 North America Pentavalent Vaccine Production (2018-2029)
1.3.5 Europe Pentavalent Vaccine Production (2018-2029)
1.3.6 China Pentavalent Vaccine Production (2018-2029)
1.3.7 Japan Pentavalent Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pentavalent Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pentavalent Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Pentavalent Vaccine Demand (2018-2029)
2.2 World Pentavalent Vaccine Consumption by Region
2.2.1 World Pentavalent Vaccine Consumption by Region (2018-2023)
2.2.2 World Pentavalent Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Pentavalent Vaccine Consumption (2018-2029)
2.4 China Pentavalent Vaccine Consumption (2018-2029)
2.5 Europe Pentavalent Vaccine Consumption (2018-2029)
2.6 Japan Pentavalent Vaccine Consumption (2018-2029)
2.7 South Korea Pentavalent Vaccine Consumption (2018-2029)
2.8 ASEAN Pentavalent Vaccine Consumption (2018-2029)
2.9 India Pentavalent Vaccine Consumption (2018-2029)
3 WORLD PENTAVALENT VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Pentavalent Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Pentavalent Vaccine Production by Manufacturer (2018-2023)
3.3 World Pentavalent Vaccine Average Price by Manufacturer (2018-2023)
3.4 Pentavalent Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Pentavalent Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Pentavalent Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Pentavalent Vaccine in 2022
3.6 Pentavalent Vaccine Market: Overall Company Footprint Analysis
3.6.1 Pentavalent Vaccine Market: Region Footprint
3.6.2 Pentavalent Vaccine Market: Company Product Type Footprint
3.6.3 Pentavalent Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Pentavalent Vaccine Production Value Comparison
4.1.1 United States VS China: Pentavalent Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Pentavalent Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Pentavalent Vaccine Production Comparison
4.2.1 United States VS China: Pentavalent Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Pentavalent Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Pentavalent Vaccine Consumption Comparison
4.3.1 United States VS China: Pentavalent Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Pentavalent Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Pentavalent Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Pentavalent Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Pentavalent Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Pentavalent Vaccine Production (2018-2023)
4.5 China Based Pentavalent Vaccine Manufacturers and Market Share
4.5.1 China Based Pentavalent Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Pentavalent Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Pentavalent Vaccine Production (2018-2023)
4.6 Rest of World Based Pentavalent Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Pentavalent Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Pentavalent Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Pentavalent Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Pentavalent Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Lyophilized
5.2.2 Liquid
5.3 Market Segment by Type
5.3.1 World Pentavalent Vaccine Production by Type (2018-2029)
5.3.2 World Pentavalent Vaccine Production Value by Type (2018-2029)
5.3.3 World Pentavalent Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Pentavalent Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Retail Pharmacy
6.2.2 Hospital Pharmacy
6.2.3 E-commerce
6.3 Market Segment by Application
6.3.1 World Pentavalent Vaccine Production by Application (2018-2029)
6.3.2 World Pentavalent Vaccine Production Value by Application (2018-2029)
6.3.3 World Pentavalent Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Serum Institute of India
7.1.1 Serum Institute of India Details
7.1.2 Serum Institute of India Major Business
7.1.3 Serum Institute of India Pentavalent Vaccine Product and Services
7.1.4 Serum Institute of India Pentavalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Serum Institute of India Recent Developments/Updates
7.1.6 Serum Institute of India Competitive Strengths & Weaknesses
7.2 Panacea Drugs Pvt. Ltd
7.2.1 Panacea Drugs Pvt. Ltd Details
7.2.2 Panacea Drugs Pvt. Ltd Major Business
7.2.3 Panacea Drugs Pvt. Ltd Pentavalent Vaccine Product and Services
7.2.4 Panacea Drugs Pvt. Ltd Pentavalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Panacea Drugs Pvt. Ltd Recent Developments/Updates
7.2.6 Panacea Drugs Pvt. Ltd Competitive Strengths & Weaknesses
7.3 Shantha Biotechnics
7.3.1 Shantha Biotechnics Details
7.3.2 Shantha Biotechnics Major Business
7.3.3 Shantha Biotechnics Pentavalent Vaccine Product and Services
7.3.4 Shantha Biotechnics Pentavalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Shantha Biotechnics Recent Developments/Updates
7.3.6 Shantha Biotechnics Competitive Strengths & Weaknesses
7.4 Biological E. Ltd.
7.4.1 Biological E. Ltd. Details
7.4.2 Biological E. Ltd. Major Business
7.4.3 Biological E. Ltd. Pentavalent Vaccine Product and Services
7.4.4 Biological E. Ltd. Pentavalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Biological E. Ltd. Recent Developments/Updates
7.4.6 Biological E. Ltd. Competitive Strengths & Weaknesses
7.5 Novartis AG
7.5.1 Novartis AG Details
7.5.2 Novartis AG Major Business
7.5.3 Novartis AG Pentavalent Vaccine Product and Services
7.5.4 Novartis AG Pentavalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Novartis AG Recent Developments/Updates
7.5.6 Novartis AG Competitive Strengths & Weaknesses
7.6 Crucell
7.6.1 Crucell Details
7.6.2 Crucell Major Business
7.6.3 Crucell Pentavalent Vaccine Product and Services
7.6.4 Crucell Pentavalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Crucell Recent Developments/Updates
7.6.6 Crucell Competitive Strengths & Weaknesses
7.7 Bio Farma
7.7.1 Bio Farma Details
7.7.2 Bio Farma Major Business
7.7.3 Bio Farma Pentavalent Vaccine Product and Services
7.7.4 Bio Farma Pentavalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Bio Farma Recent Developments/Updates
7.7.6 Bio Farma Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Pentavalent Vaccine Industry Chain
8.2 Pentavalent Vaccine Upstream Analysis
8.2.1 Pentavalent Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Pentavalent Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Pentavalent Vaccine Production Mode
8.6 Pentavalent Vaccine Procurement Model
8.7 Pentavalent Vaccine Industry Sales Model and Sales Channels
8.7.1 Pentavalent Vaccine Sales Model
8.7.2 Pentavalent Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Pentavalent Vaccine Introduction
1.2 World Pentavalent Vaccine Supply & Forecast
1.2.1 World Pentavalent Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Pentavalent Vaccine Production (2018-2029)
1.2.3 World Pentavalent Vaccine Pricing Trends (2018-2029)
1.3 World Pentavalent Vaccine Production by Region (Based on Production Site)
1.3.1 World Pentavalent Vaccine Production Value by Region (2018-2029)
1.3.2 World Pentavalent Vaccine Production by Region (2018-2029)
1.3.3 World Pentavalent Vaccine Average Price by Region (2018-2029)
1.3.4 North America Pentavalent Vaccine Production (2018-2029)
1.3.5 Europe Pentavalent Vaccine Production (2018-2029)
1.3.6 China Pentavalent Vaccine Production (2018-2029)
1.3.7 Japan Pentavalent Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pentavalent Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pentavalent Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Pentavalent Vaccine Demand (2018-2029)
2.2 World Pentavalent Vaccine Consumption by Region
2.2.1 World Pentavalent Vaccine Consumption by Region (2018-2023)
2.2.2 World Pentavalent Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Pentavalent Vaccine Consumption (2018-2029)
2.4 China Pentavalent Vaccine Consumption (2018-2029)
2.5 Europe Pentavalent Vaccine Consumption (2018-2029)
2.6 Japan Pentavalent Vaccine Consumption (2018-2029)
2.7 South Korea Pentavalent Vaccine Consumption (2018-2029)
2.8 ASEAN Pentavalent Vaccine Consumption (2018-2029)
2.9 India Pentavalent Vaccine Consumption (2018-2029)
3 WORLD PENTAVALENT VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Pentavalent Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Pentavalent Vaccine Production by Manufacturer (2018-2023)
3.3 World Pentavalent Vaccine Average Price by Manufacturer (2018-2023)
3.4 Pentavalent Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Pentavalent Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Pentavalent Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Pentavalent Vaccine in 2022
3.6 Pentavalent Vaccine Market: Overall Company Footprint Analysis
3.6.1 Pentavalent Vaccine Market: Region Footprint
3.6.2 Pentavalent Vaccine Market: Company Product Type Footprint
3.6.3 Pentavalent Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Pentavalent Vaccine Production Value Comparison
4.1.1 United States VS China: Pentavalent Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Pentavalent Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Pentavalent Vaccine Production Comparison
4.2.1 United States VS China: Pentavalent Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Pentavalent Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Pentavalent Vaccine Consumption Comparison
4.3.1 United States VS China: Pentavalent Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Pentavalent Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Pentavalent Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Pentavalent Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Pentavalent Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Pentavalent Vaccine Production (2018-2023)
4.5 China Based Pentavalent Vaccine Manufacturers and Market Share
4.5.1 China Based Pentavalent Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Pentavalent Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Pentavalent Vaccine Production (2018-2023)
4.6 Rest of World Based Pentavalent Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Pentavalent Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Pentavalent Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Pentavalent Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Pentavalent Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Lyophilized
5.2.2 Liquid
5.3 Market Segment by Type
5.3.1 World Pentavalent Vaccine Production by Type (2018-2029)
5.3.2 World Pentavalent Vaccine Production Value by Type (2018-2029)
5.3.3 World Pentavalent Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Pentavalent Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Retail Pharmacy
6.2.2 Hospital Pharmacy
6.2.3 E-commerce
6.3 Market Segment by Application
6.3.1 World Pentavalent Vaccine Production by Application (2018-2029)
6.3.2 World Pentavalent Vaccine Production Value by Application (2018-2029)
6.3.3 World Pentavalent Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Serum Institute of India
7.1.1 Serum Institute of India Details
7.1.2 Serum Institute of India Major Business
7.1.3 Serum Institute of India Pentavalent Vaccine Product and Services
7.1.4 Serum Institute of India Pentavalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Serum Institute of India Recent Developments/Updates
7.1.6 Serum Institute of India Competitive Strengths & Weaknesses
7.2 Panacea Drugs Pvt. Ltd
7.2.1 Panacea Drugs Pvt. Ltd Details
7.2.2 Panacea Drugs Pvt. Ltd Major Business
7.2.3 Panacea Drugs Pvt. Ltd Pentavalent Vaccine Product and Services
7.2.4 Panacea Drugs Pvt. Ltd Pentavalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Panacea Drugs Pvt. Ltd Recent Developments/Updates
7.2.6 Panacea Drugs Pvt. Ltd Competitive Strengths & Weaknesses
7.3 Shantha Biotechnics
7.3.1 Shantha Biotechnics Details
7.3.2 Shantha Biotechnics Major Business
7.3.3 Shantha Biotechnics Pentavalent Vaccine Product and Services
7.3.4 Shantha Biotechnics Pentavalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Shantha Biotechnics Recent Developments/Updates
7.3.6 Shantha Biotechnics Competitive Strengths & Weaknesses
7.4 Biological E. Ltd.
7.4.1 Biological E. Ltd. Details
7.4.2 Biological E. Ltd. Major Business
7.4.3 Biological E. Ltd. Pentavalent Vaccine Product and Services
7.4.4 Biological E. Ltd. Pentavalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Biological E. Ltd. Recent Developments/Updates
7.4.6 Biological E. Ltd. Competitive Strengths & Weaknesses
7.5 Novartis AG
7.5.1 Novartis AG Details
7.5.2 Novartis AG Major Business
7.5.3 Novartis AG Pentavalent Vaccine Product and Services
7.5.4 Novartis AG Pentavalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Novartis AG Recent Developments/Updates
7.5.6 Novartis AG Competitive Strengths & Weaknesses
7.6 Crucell
7.6.1 Crucell Details
7.6.2 Crucell Major Business
7.6.3 Crucell Pentavalent Vaccine Product and Services
7.6.4 Crucell Pentavalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Crucell Recent Developments/Updates
7.6.6 Crucell Competitive Strengths & Weaknesses
7.7 Bio Farma
7.7.1 Bio Farma Details
7.7.2 Bio Farma Major Business
7.7.3 Bio Farma Pentavalent Vaccine Product and Services
7.7.4 Bio Farma Pentavalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Bio Farma Recent Developments/Updates
7.7.6 Bio Farma Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Pentavalent Vaccine Industry Chain
8.2 Pentavalent Vaccine Upstream Analysis
8.2.1 Pentavalent Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Pentavalent Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Pentavalent Vaccine Production Mode
8.6 Pentavalent Vaccine Procurement Model
8.7 Pentavalent Vaccine Industry Sales Model and Sales Channels
8.7.1 Pentavalent Vaccine Sales Model
8.7.2 Pentavalent Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Pentavalent Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Pentavalent Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Pentavalent Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Pentavalent Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Pentavalent Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Pentavalent Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Pentavalent Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Pentavalent Vaccine Production Market Share by Region (2018-2023)
Table 9. World Pentavalent Vaccine Production Market Share by Region (2024-2029)
Table 10. World Pentavalent Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Pentavalent Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Pentavalent Vaccine Major Market Trends
Table 13. World Pentavalent Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Pentavalent Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Pentavalent Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Pentavalent Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Pentavalent Vaccine Producers in 2022
Table 18. World Pentavalent Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Pentavalent Vaccine Producers in 2022
Table 20. World Pentavalent Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Pentavalent Vaccine Company Evaluation Quadrant
Table 22. World Pentavalent Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Pentavalent Vaccine Production Site of Key Manufacturer
Table 24. Pentavalent Vaccine Market: Company Product Type Footprint
Table 25. Pentavalent Vaccine Market: Company Product Application Footprint
Table 26. Pentavalent Vaccine Competitive Factors
Table 27. Pentavalent Vaccine New Entrant and Capacity Expansion Plans
Table 28. Pentavalent Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Pentavalent Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Pentavalent Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Pentavalent Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Pentavalent Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Pentavalent Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Pentavalent Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Pentavalent Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Pentavalent Vaccine Production Market Share (2018-2023)
Table 37. China Based Pentavalent Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Pentavalent Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Pentavalent Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Pentavalent Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Pentavalent Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Pentavalent Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Pentavalent Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Pentavalent Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Pentavalent Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Pentavalent Vaccine Production Market Share (2018-2023)
Table 47. World Pentavalent Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Pentavalent Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Pentavalent Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Pentavalent Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Pentavalent Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Pentavalent Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Pentavalent Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Pentavalent Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Pentavalent Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Pentavalent Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Pentavalent Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Pentavalent Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Pentavalent Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Pentavalent Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 62. Serum Institute of India Major Business
Table 63. Serum Institute of India Pentavalent Vaccine Product and Services
Table 64. Serum Institute of India Pentavalent Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Serum Institute of India Recent Developments/Updates
Table 66. Serum Institute of India Competitive Strengths & Weaknesses
Table 67. Panacea Drugs Pvt. Ltd Basic Information, Manufacturing Base and Competitors
Table 68. Panacea Drugs Pvt. Ltd Major Business
Table 69. Panacea Drugs Pvt. Ltd Pentavalent Vaccine Product and Services
Table 70. Panacea Drugs Pvt. Ltd Pentavalent Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Panacea Drugs Pvt. Ltd Recent Developments/Updates
Table 72. Panacea Drugs Pvt. Ltd Competitive Strengths & Weaknesses
Table 73. Shantha Biotechnics Basic Information, Manufacturing Base and Competitors
Table 74. Shantha Biotechnics Major Business
Table 75. Shantha Biotechnics Pentavalent Vaccine Product and Services
Table 76. Shantha Biotechnics Pentavalent Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Shantha Biotechnics Recent Developments/Updates
Table 78. Shantha Biotechnics Competitive Strengths & Weaknesses
Table 79. Biological E. Ltd. Basic Information, Manufacturing Base and Competitors
Table 80. Biological E. Ltd. Major Business
Table 81. Biological E. Ltd. Pentavalent Vaccine Product and Services
Table 82. Biological E. Ltd. Pentavalent Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Biological E. Ltd. Recent Developments/Updates
Table 84. Biological E. Ltd. Competitive Strengths & Weaknesses
Table 85. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 86. Novartis AG Major Business
Table 87. Novartis AG Pentavalent Vaccine Product and Services
Table 88. Novartis AG Pentavalent Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Novartis AG Recent Developments/Updates
Table 90. Novartis AG Competitive Strengths & Weaknesses
Table 91. Crucell Basic Information, Manufacturing Base and Competitors
Table 92. Crucell Major Business
Table 93. Crucell Pentavalent Vaccine Product and Services
Table 94. Crucell Pentavalent Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Crucell Recent Developments/Updates
Table 96. Bio Farma Basic Information, Manufacturing Base and Competitors
Table 97. Bio Farma Major Business
Table 98. Bio Farma Pentavalent Vaccine Product and Services
Table 99. Bio Farma Pentavalent Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 100. Global Key Players of Pentavalent Vaccine Upstream (Raw Materials)
Table 101. Pentavalent Vaccine Typical Customers
Table 102. Pentavalent Vaccine Typical Distributors
Table 1. World Pentavalent Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Pentavalent Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Pentavalent Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Pentavalent Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Pentavalent Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Pentavalent Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Pentavalent Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Pentavalent Vaccine Production Market Share by Region (2018-2023)
Table 9. World Pentavalent Vaccine Production Market Share by Region (2024-2029)
Table 10. World Pentavalent Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Pentavalent Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Pentavalent Vaccine Major Market Trends
Table 13. World Pentavalent Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Pentavalent Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Pentavalent Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Pentavalent Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Pentavalent Vaccine Producers in 2022
Table 18. World Pentavalent Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Pentavalent Vaccine Producers in 2022
Table 20. World Pentavalent Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Pentavalent Vaccine Company Evaluation Quadrant
Table 22. World Pentavalent Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Pentavalent Vaccine Production Site of Key Manufacturer
Table 24. Pentavalent Vaccine Market: Company Product Type Footprint
Table 25. Pentavalent Vaccine Market: Company Product Application Footprint
Table 26. Pentavalent Vaccine Competitive Factors
Table 27. Pentavalent Vaccine New Entrant and Capacity Expansion Plans
Table 28. Pentavalent Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Pentavalent Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Pentavalent Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Pentavalent Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Pentavalent Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Pentavalent Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Pentavalent Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Pentavalent Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Pentavalent Vaccine Production Market Share (2018-2023)
Table 37. China Based Pentavalent Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Pentavalent Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Pentavalent Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Pentavalent Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Pentavalent Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Pentavalent Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Pentavalent Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Pentavalent Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Pentavalent Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Pentavalent Vaccine Production Market Share (2018-2023)
Table 47. World Pentavalent Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Pentavalent Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Pentavalent Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Pentavalent Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Pentavalent Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Pentavalent Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Pentavalent Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Pentavalent Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Pentavalent Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Pentavalent Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Pentavalent Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Pentavalent Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Pentavalent Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Pentavalent Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 62. Serum Institute of India Major Business
Table 63. Serum Institute of India Pentavalent Vaccine Product and Services
Table 64. Serum Institute of India Pentavalent Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Serum Institute of India Recent Developments/Updates
Table 66. Serum Institute of India Competitive Strengths & Weaknesses
Table 67. Panacea Drugs Pvt. Ltd Basic Information, Manufacturing Base and Competitors
Table 68. Panacea Drugs Pvt. Ltd Major Business
Table 69. Panacea Drugs Pvt. Ltd Pentavalent Vaccine Product and Services
Table 70. Panacea Drugs Pvt. Ltd Pentavalent Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Panacea Drugs Pvt. Ltd Recent Developments/Updates
Table 72. Panacea Drugs Pvt. Ltd Competitive Strengths & Weaknesses
Table 73. Shantha Biotechnics Basic Information, Manufacturing Base and Competitors
Table 74. Shantha Biotechnics Major Business
Table 75. Shantha Biotechnics Pentavalent Vaccine Product and Services
Table 76. Shantha Biotechnics Pentavalent Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Shantha Biotechnics Recent Developments/Updates
Table 78. Shantha Biotechnics Competitive Strengths & Weaknesses
Table 79. Biological E. Ltd. Basic Information, Manufacturing Base and Competitors
Table 80. Biological E. Ltd. Major Business
Table 81. Biological E. Ltd. Pentavalent Vaccine Product and Services
Table 82. Biological E. Ltd. Pentavalent Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Biological E. Ltd. Recent Developments/Updates
Table 84. Biological E. Ltd. Competitive Strengths & Weaknesses
Table 85. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 86. Novartis AG Major Business
Table 87. Novartis AG Pentavalent Vaccine Product and Services
Table 88. Novartis AG Pentavalent Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Novartis AG Recent Developments/Updates
Table 90. Novartis AG Competitive Strengths & Weaknesses
Table 91. Crucell Basic Information, Manufacturing Base and Competitors
Table 92. Crucell Major Business
Table 93. Crucell Pentavalent Vaccine Product and Services
Table 94. Crucell Pentavalent Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Crucell Recent Developments/Updates
Table 96. Bio Farma Basic Information, Manufacturing Base and Competitors
Table 97. Bio Farma Major Business
Table 98. Bio Farma Pentavalent Vaccine Product and Services
Table 99. Bio Farma Pentavalent Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 100. Global Key Players of Pentavalent Vaccine Upstream (Raw Materials)
Table 101. Pentavalent Vaccine Typical Customers
Table 102. Pentavalent Vaccine Typical Distributors
LIST OF FIGURES
Figure 1. Pentavalent Vaccine Picture
Figure 2. World Pentavalent Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Pentavalent Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Pentavalent Vaccine Production (2018-2029) & (K Units)
Figure 5. World Pentavalent Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Pentavalent Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Pentavalent Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Pentavalent Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe Pentavalent Vaccine Production (2018-2029) & (K Units)
Figure 10. China Pentavalent Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan Pentavalent Vaccine Production (2018-2029) & (K Units)
Figure 12. Pentavalent Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Pentavalent Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World Pentavalent Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Pentavalent Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China Pentavalent Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe Pentavalent Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan Pentavalent Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Pentavalent Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Pentavalent Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India Pentavalent Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Pentavalent Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Pentavalent Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Pentavalent Vaccine Markets in 2022
Figure 26. United States VS China: Pentavalent Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Pentavalent Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Pentavalent Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Pentavalent Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Pentavalent Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Pentavalent Vaccine Production Market Share 2022
Figure 32. World Pentavalent Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Pentavalent Vaccine Production Value Market Share by Type in 2022
Figure 34. Lyophilized
Figure 35. Liquid
Figure 36. World Pentavalent Vaccine Production Market Share by Type (2018-2029)
Figure 37. World Pentavalent Vaccine Production Value Market Share by Type (2018-2029)
Figure 38. World Pentavalent Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Pentavalent Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Pentavalent Vaccine Production Value Market Share by Application in 2022
Figure 41. Retail Pharmacy
Figure 42. Hospital Pharmacy
Figure 43. E-commerce
Figure 44. World Pentavalent Vaccine Production Market Share by Application (2018-2029)
Figure 45. World Pentavalent Vaccine Production Value Market Share by Application (2018-2029)
Figure 46. World Pentavalent Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Pentavalent Vaccine Industry Chain
Figure 48. Pentavalent Vaccine Procurement Model
Figure 49. Pentavalent Vaccine Sales Model
Figure 50. Pentavalent Vaccine Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Pentavalent Vaccine Picture
Figure 2. World Pentavalent Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Pentavalent Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Pentavalent Vaccine Production (2018-2029) & (K Units)
Figure 5. World Pentavalent Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Pentavalent Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Pentavalent Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Pentavalent Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe Pentavalent Vaccine Production (2018-2029) & (K Units)
Figure 10. China Pentavalent Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan Pentavalent Vaccine Production (2018-2029) & (K Units)
Figure 12. Pentavalent Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Pentavalent Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World Pentavalent Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Pentavalent Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China Pentavalent Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe Pentavalent Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan Pentavalent Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Pentavalent Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Pentavalent Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India Pentavalent Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Pentavalent Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Pentavalent Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Pentavalent Vaccine Markets in 2022
Figure 26. United States VS China: Pentavalent Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Pentavalent Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Pentavalent Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Pentavalent Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Pentavalent Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Pentavalent Vaccine Production Market Share 2022
Figure 32. World Pentavalent Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Pentavalent Vaccine Production Value Market Share by Type in 2022
Figure 34. Lyophilized
Figure 35. Liquid
Figure 36. World Pentavalent Vaccine Production Market Share by Type (2018-2029)
Figure 37. World Pentavalent Vaccine Production Value Market Share by Type (2018-2029)
Figure 38. World Pentavalent Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Pentavalent Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Pentavalent Vaccine Production Value Market Share by Application in 2022
Figure 41. Retail Pharmacy
Figure 42. Hospital Pharmacy
Figure 43. E-commerce
Figure 44. World Pentavalent Vaccine Production Market Share by Application (2018-2029)
Figure 45. World Pentavalent Vaccine Production Value Market Share by Application (2018-2029)
Figure 46. World Pentavalent Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Pentavalent Vaccine Industry Chain
Figure 48. Pentavalent Vaccine Procurement Model
Figure 49. Pentavalent Vaccine Sales Model
Figure 50. Pentavalent Vaccine Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
